RESUMO
This prospective trial was designed to assess aesthetic outcomes of oncoplastic surgery. Standardized photographs were taken of 45 breast cancer patients undergoing oncoplastic surgery, preoperatively and 6 and 12 months postoperatively (oncoplastic group), and of 45 patients treated by conservative surgery without breast reconstruction (control group). Photographs were assessed by senior male and female physicians, 2 breast surgeons and 2 plastic surgeons. Aesthetic outcomes were evaluated using patients' own assessments (rated 0 to 10) and scoring by panelists (using 0 to 10 global rating scales and a subscales system). Patients in both groups scored the aesthetic outcomes better than physicians did. Panelists and patients considered aesthetic outcomes of oncoplastic group better than control group outcomes. Patients and plastic surgeons attributed progressively higher grades to outcomes of oncoplastic group at 6 and 12 months postoperatively; breast surgeons did not. Overall, female physicians and breast surgeons scored better the aesthetic outcomes of both groups.
